Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E.Y. Park

P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy

Journal of Thoracic Oncology

English

P3.17-07 the Beneficial Effect of the High Dose Irradiation During Concurrent Chemoradiotherapy in Locoregional Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Related publications

Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC

Materia Socio Medica

2016

English

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) Using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P2.17-05 Consolidation Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy

Journal of Thoracic Oncology

English

Clinical Efficacy and Prognostic Factors in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy

Med One

2017

English

P2.17-30 Serum Lipoprotein(A) Correlates With the Effect of Endostar Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced LSCC

Journal of Thoracic Oncology

English

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

Przeglad Gastroenterologiczny

Gastroenterology

2018

English

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated With Immunotherapy and Ramucirumab Plus Docetaxel.

Journal of Thoracic Oncology

English

Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients With Advanced Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2011

English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E.Y. Park

P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy

P3.17-07 the Beneficial Effect of the High Dose Irradiation During Concurrent Chemoradiotherapy in Locoregional Advanced Non-Small Cell Lung Cancer

Related publications

Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) Using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

P2.17-05 Consolidation Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy

Clinical Efficacy and Prognostic Factors in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy

P2.17-30 Serum Lipoprotein(A) Correlates With the Effect of Endostar Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced LSCC

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated With Immunotherapy and Ramucirumab Plus Docetaxel.

Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients With Advanced Colorectal Cancer

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab